Study guide

5.4 Patient Profile Records, Confidentiality & Permitted Disclosures

New Jersey MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Board of Pharmacy Governance & Pharmacist Licensure

1.1 New Jersey State Board of Pharmacy Structure, Jurisdiction & Rulemaking 1.2 Pharmacist Licensure by Examination & Reciprocity 1.3 Practical Experience & Pharmacy Internship Requirements 1.4 Pharmacist License Renewal & Mandatory Continuing Education

2 Chapter 2: Pharmacy Support Personnel & Supervision Standards

2.1 Pharmacy Technician Registration, Qualifications & Scope of Duties 2.2 Pharmacist-to-Technician Ratios & Training Requirements 2.3 Pharmacist-in-Charge (RPIC) Duties, Hours & Operational Accountability

3 Chapter 3: Prescription Validity, Issuance & Federal/State Standards

3.1 Legal Elements of a Valid Prescription in New Jersey 3.2 New Jersey Prescription Blanks (NJPB) & Security Specifications 3.3 Electronic Prescribing of Controlled Substances (EPCS) & Transmission Rules

4 Chapter 4: Controlled Substance Dispensing & Opioid Safeguards

4.1 Schedule II Prescription Requirements & Time Limitations 4.2 Acute Pain Opioid Restrictions & Pediatric Safeguards 4.3 Emergency Schedule II Dispensing & Partial Fills 4.4 Naloxone Access, Standing Orders & Overdose Prevention

5 Chapter 5: Clinical Services, Immunizations & Collaborative Practice

5.1 Pharmacist Administration of Vaccines & Immunizations 5.2 Collaborative Drug Therapy Management (CDTM) & Clinical Protocols 5.3 Patient Counseling & Prospective Drug Utilization Review (DUR) 5.4 Patient Profile Records, Confidentiality & Permitted Disclosures 5.5 Continuous Quality Improvement, Error Prevention & Public Health Duties

6 Chapter 6: Prescription Processing, Generic Substitution & Labeling

6.1 Generic Substitution Law & Orange Book Equivalence 6.2 Prescription Labeling & Auxiliary Warnings 6.3 Refill Authorizations & Emergency Maintenance Dispensing 6.4 Returning, Reusing & Re-Dispensing Prescription Medication

7 Chapter 7: Prescription Transfers & Monitoring Program (NJPMP)

7.1 Prescription Transfer Rules & Audit Trails 7.2 New Jersey Prescription Monitoring Program (NJPMP) Compliance 7.3 Central Fill, Remote Processing & Mail-Order Operations 7.4 Delivery of Drugs: Will-Call, Agent Pickup, Courier & Mail

8 Chapter 8: Federal Packaging, Tampering & Distribution Standards

8.1 Poison Prevention Packaging Act (PPPA) & Child-Resistant Standards 8.2 Federal Anti-Tampering Act & Over-the-Counter Regulations 8.3 Drug Supply Chain Security Act (DSCSA) & Track-and-Trace 8.4 Drug Product Conditions Prohibiting Dispensing: Recalls, Outdated Stock & Adulteration

9 Chapter 9: Pharmacy Facility Standards, Permits & Security

9.1 Pharmacy Permits, Space & Equipment Requirements 9.2 Physical Security, Alarm Systems & Temporary Closures 9.3 Institutional & Health Care Facility Pharmacy Practice

10 Chapter 10: Controlled Substance Records, Inventory & Disciplinary Actions

10.1 Controlled Substance Ordering, CSOS & DEA Form 222 10.2 Inventory Audits, Theft Reporting & Disposal Protocols 10.3 Disciplinary Actions, Board Inspections & Professional Impairment

11 Chapter 11: Non-Sterile & Sterile Compounding Standards

11.1 USP <795> Non-Sterile Compounding & NJ Standards 11.2 USP <797> Sterile Compounding & Cleanroom Specifications 11.3 USP <800> Hazardous Drug Handling & Safety Protections

5.4 Patient Profile Records, Confidentiality & Permitted Disclosures

Key Takeaways Explain This Topic AI

N.J.A.C. 13:39-7.19 requires a patient profile record system and states the governing rule in one sentence: patient records shall be kept confidential, but shall be made available to persons authorized to inspect them under State and Federal statutes and regulations.

The pharmacist's own clinical comments belong in the profile — the profile is a working clinical record that feeds the mandatory DUR under 13:39-7.20, not merely a billing history.

Under N.J.A.C. 13:39-7.7, a pharmacy must comply immediately with a patient's request for copies of prescriptions and/or the patient profile: within 24 hours for prescriptions filled within the past year, and within 72 hours for older ones.

NJPMP data carries a second, stricter confidentiality regime under N.J.S.A. 45:1-45 et seq.: credentials are individual and non-shareable, delegates must hold their own registered accounts, and unauthorized access or disclosure is independently sanctionable.

Federal HIPAA sets a floor rather than a ceiling — where New Jersey law, 42 CFR Part 2 substance-use-disorder rules, or the NJPMP statute is more protective, the more protective rule controls.

Last updated: September 2026

5.4 Patient Profile Records, Confidentiality & Permitted Disclosures

Note

Core Legal Authorities : New Jersey State Board of Pharmacy rules on the patient profile record system and confidentiality ( N.J.A.C. 13:39-7.19 ), copies of prescriptions and profiles ( N.J.A.C. 13:39-7.7 ), drug utilization review ( N.J.A.C. 13:39-7.20 ), the New Jersey Prescription Monitoring Program statute ( N.J.S.A. 45:1-45 et seq. ) and rules ( N.J.A.C. 13:45A-35 ), the federal HIPAA Privacy Rule ( 45 CFR Parts 160 and 164 ), and the federal substance-use-disorder confidentiality rules at 42 CFR Part 2 .

The MPJE Competency Statements devote an entire item to "protecting patient and health record confidentiality," and New Jersey tests it in a specific way: not as an abstract HIPAA quiz, but as a set of counter-scenarios in which someone standing at the counter or on the telephone wants information, and you must decide whether the law permits, compels, or forbids the disclosure.

The Profile Is a Clinical Record, Not a Transaction Log

N.J.A.C. 13:39-7.19 requires every New Jersey pharmacy to maintain a patient profile record system . The profile is what makes the mandatory prospective drug utilization review under 13:39-7.20 possible: on receipt of a new or refill prescription, the pharmacist examines the profile before dispensing to identify potentially significant interactions, reactions, or misutilization. A profile that contains only fill dates and NDC numbers cannot support that screen.

A usable New Jersey profile therefore captures:

  • Element Why the Board Requires It
  • Patient name, address, date of birth, gender Identity resolution; age-based dosing and screening
  • Known allergies and drug reactions The drug-allergy limb of the 13:39-7.20 screen
  • Chronic conditions and disease states The drug-disease contraindication limb

Comprehensive medication history, including relevant OTC and supplement use when known Duplication and interaction screening

The pharmacist's own comments relevant to drug therapy Continuity between shifts; evidence the DUR was performed

That last row is the one candidates skip. The rule contemplates that a pharmacist will write in the profile — a documented intervention, a prescriber consultation, a counseling refusal. In a Board investigation, an undocumented intervention is functionally an intervention that never happened.

The Confidentiality Rule Itself

The operative language of N.J.A.C. 13:39-7.19 is compact and worth memorizing close to verbatim: patient records shall be kept confidential , but shall be made available to persons authorized to inspect them under State and Federal statutes and regulations.

  • Read as a two-part test, that sentence answers most exam scenarios: Someone requests patient information
  • │
  • ┌───────────────┴───────────────┐
  • ▼ ▼
  • Is the requester AUTHORIZED Not authorized by any
  • by a State or Federal statute State or Federal statute
  • or regulation to inspect? │
  • │ ▼

▼ DEFAULT: confidential.

  • Disclosure permitted (and Do not disclose. Patient
  • sometimes compelled) within authorization or a valid

the scope of that authority. legal process is required.

Requesters Who Are Ordinarily Authorized

The patient , and a personal representative acting on the patient's behalf.

Board of Pharmacy inspectors and Division of Consumer Affairs investigators , exercising the inspection authority discussed in the disciplinary chapter — an inspector does not need a warrant or the patient's consent to review dispensing records.

Practitioners involved in the patient's care, and other pharmacists, for treatment purposes.

DEA and other regulators acting within their statutory authority over controlled substance records.

Payors , for payment and health care operations within the HIPAA framework.

Requesters Who Are Not

A spouse, adult child, or parent of an adult patient who simply asks what the patient is taking. Family relationship is not authorization. HIPAA permits limited disclosure to a person involved in the patient's care where the patient does not object and the information is directly relevant to that involvement — which covers handing a prescription bag to the spouse picking it up, not reciting the patient's medication history.

An employer verifying what an employee takes.

Law enforcement making an informal request without a subpoena, warrant, or other legal process. The correct response is not refusal-with-attitude; it is to decline the informal request and ask for the appropriate legal process, while immediately preserving the records.

The Patient's Right to Copies — With a Clock

N.J.A.C. 13:39-7.7 obliges a pharmacy to comply immediately with a patient's request for copies of prescriptions and/or the patient profile, and it defines "immediately" numerically:

  • Request Concerns Maximum Time to Produce
  • Prescriptions filled one year or less from the original fill date 24 hours
  • All other prescriptions 72 hours

Two related traps live in the same rule. A copy issued directly to the patient must bear, in letters at least as large as those describing the medication, the underlined statement "COPY — FOR INFORMATION ONLY." And presenting such a copy — or simply presenting a labeled prescription container — has no legal status as a valid prescription order . A pharmacist handed a labeled vial from another pharmacy must contact the prescriber for a new prescription or arrange a transfer under 13:39-7.8; the pharmacist may not dispense from the label.

NJPMP Data: A Second, Stricter Regime

Program data under N.J.S.A. 45:1-45 et seq. is not ordinary pharmacy record material, and the exam treats it separately:

Credentials are individual. Each authorized user holds a personal registered account. Sharing a user ID or password with a colleague — even a licensed colleague who is entitled to their own account — is a violation in itself.

Delegates must be registered. A practitioner may delegate querying, but only to a health care delegate who holds an individual registered account with the Division of Consumer Affairs.

Query only within the professional relationship. Looking up a neighbor, a job applicant, or a family member is unauthorized access regardless of curiosity or good intentions, and it is auditable — the system logs every query against the querying account.

Unauthorized access or disclosure exposes the licensee to civil penalties, license discipline, and potential criminal liability, independent of any HIPAA exposure.

How the Layers Stack

Source Scope Effect in New Jersey

HIPAA Privacy Rule (45 CFR Parts 160, 164) All protected health information held by covered entities A floor . It expressly does not preempt more protective State law.

N.J.A.C. 13:39-7.19 Pharmacy patient records Confidential by default; disclosure only to those authorized by law.

NJPMP statute and rules Controlled substance dispensing data Stricter than HIPAA on who may query and how credentials are handled.

42 CFR Part 2 Records of federally assisted substance use disorder programs Stricter than HIPAA; generally requires specific written consent, and a HIPAA-style treatment disclosure is not automatically permitted.

The governing principle when two of these conflict is not "HIPAA wins." It is that the more protective rule controls. A candidate who answers a Part 2 or NJPMP question with a generic HIPAA treatment-disclosure rationale will get it wrong.

Practice Scenarios

Scenario 1 — The concerned adult child. A woman asks the pharmacist whether her 78-year-old father, a competent adult who lives independently, is still filling his warfarin. She is not his personal representative and he has never authorized disclosure. Analysis: Decline. Being an adult child is not authorization under 13:39-7.19, and HIPAA's involvement-in-care provision does not extend to reciting a medication history to a relative who is not picking up the prescription and whose involvement the patient has not acknowledged. The professional move is to offer to speak with the father directly and to invite him to authorize disclosure.

Scenario 2 — The detective at the counter. A municipal detective, in uniform and without a subpoena, asks for the dispensing history of a named patient in a diversion investigation. Analysis: An informal request is not legal process. Decline the informal request, ask for a subpoena, warrant, or other lawful authority, and preserve the records — do not alter or purge anything. This is different from a Board or Division inspection , where the inspector's statutory authority is the authorization and records must be produced.

Scenario 3 — The helpful password. A newly hired pharmacist has not finished NJPMP registration and asks the RPIC to run a query under the RPIC's account so the patient is not delayed. Analysis: Refuse. Credential sharing is a discrete NJPMP violation for both pharmacists. The lawful paths are for the RPIC to run and act on the query in their own professional capacity, or for the new pharmacist to complete registration. Convenience is never a defense to a logged access violation.